广泛性焦虑障碍的联合治疗方案

Combined Treatment Regimen for Generalized Anxiety Disorder

目的探讨广泛性焦虑障碍的联合治疗方案。方法收集我院广泛性焦虑障碍的患者,患者符合ICD-10诊断标准,分为研究组(接受艾司西酞普兰与文拉法辛治疗)和对照组(接受文拉法辛治疗)。对比两组治疗前后汉密尔顿焦虑量表评分,两组治疗疗效和药物不良反应。结果两组治疗后汉密尔顿焦虑量表评分、治疗疗效比较差异有统计学意义(P<0.05);两组治疗前汉密尔顿焦虑量表评分及服用药物的不良反应发生情况比较,差异无统计意义(P>0.05)。结论艾司西酞普兰与文拉法辛联合治疗广泛性焦虑障碍疗效肯定,安全性好。

Objective To explore the combined treatment of generalized anxiety disorder （DAS）. Methods Patients with generalized anxiety disorder in our hospital were conformed to the ICD-10 diagnostic criteria, they were divided into the study group （treated with escitalopram and venlafaxine） and the control group （receiving venlafaxine treatment）. The hamilton anxiety scale was compared between the two groups before and after treatment, and the two groups were treated with therapeutic effects and adverse drug reactions. Results After the treatment of the two groups, there was a signifcant diference between the hamilton anxiety scale score and the therapeutic effect （P 〈 0.05）. There was no statistical difference between the two groups before the treatment of the Hamilton anxiety scale and the adverse drug reaction （P 〉 0.05）. Conclusion The combinationof escitalopram and venlafaxine is effective and safe in the treatment of generalized anxiety disorder.